Core Laboratories N.V.

Core Laboratories N.V. (CLB) Market Cap

Core Laboratories N.V. has a market capitalization of $490.5M.

Price: $10.64

ā–² 0.29 (2.80%)

Market Cap: 490.47M

NYSE Ā· time unavailable

CEO: Lawrence V. Bruno

Sector: Energy

Industry: Oil & Gas Equipment & Services

IPO Date: 1995-09-21

Website: https://www.corelab.com

Core Laboratories N.V. (CLB) - Company Information

Market Cap: 490.47M|Sector: Energy

Company Profile

Core Laboratories N.V. (CLB) is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction. The company's operations are distinctly segmented into Reservoir Description and Production Enhancement. The Reservoir Description division meticulously analyzes petroleum reservoir rock, fluid, and gas samples. This detailed scientific examination aims to boost the yield and enhance the recovery of oil and gas from clients' reservoirs. Offerings in this segment encompass comprehensive laboratory analysis and on-site field evaluations to determine the properties of crude oil and refined products, alongside performing proprietary and collaborative industry research studies. Conversely, the Production Enhancement segment furnishes an array of services and products vital for well completions, perforations, stimulation processes, and general production activities. This includes providing integrated diagnostic tools designed to assess the efficacy of well completions and to devise strategies for more effective enhanced oil recovery initiatives. Core Laboratories markets and sells its solutions through diverse channels, including direct sales representatives, educational seminars, industry trade exhibitions, print advertising, and a network of distributors. Established in 1936, the company boasts a significant international presence, conducting operations in approximately 50 countries, with its corporate headquarters situated in Amstelveen, the Netherlands.

Analyst Sentiment

60%
Buy

From 3 Active Polls

1Y Forecast: $25.00

ā–² +135.0% Potential Upside

Consensus Target Metrics

Low Bound

$17

Median

$26

High Bound

$32

Average

$25

Price & Moving Averages

Loading chart...

šŸŽÆ Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$25.00
ā–² +134.96% Upside
Low Target
$17.00
60% Risk
Median Target
$26.00
144% Mid
High Target
$32.00
201% Max
Consensus
Hold
16 / 37 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

šŸ“Š Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingTrailing 12MJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024
Market Cap ($M)490546774745582547701811869
Enterprise Value ($M)5075639198877236958599721,043
Price to Earnings Ratio (P/E)19.0022.40-209.8726.7210.3013.09-1135.6127.0518.53
Price/Earnings-to-Growth Ratio (PEG)—9.70—9.623.072.46——6.33
Price to Sales Ratio (P/S)0.944.386.355.394.334.205.676.276.47
Price to Book Ratio (P/B)1.791.962.882.802.142.092.773.223.47
Price to Free Cash Flow Ratio (P/FCF)22.7543.00-835.38172.88106.3854.27227.5649.9383.84
Enterprise Value to Sales (EV/Sales)—4.527.546.415.385.346.957.527.76
Enterprise Value to EBITDA (EV/EBITDA)8.0943.37162.5545.4729.5030.63105.6154.4744.42
Debt to Equity Ratio0.260.140.620.620.620.680.710.710.78

šŸ“˜ Full Research Report

ā„¹ļø

AI-Generated Research: This report is for informational purposes only.

šŸ“˜ CORE LABORATORIES INC (CLB) — Investment Overview

🧩 Business Model Overview

Core Laboratories applies advanced reservoir and production characterization tools to help oil and gas operators make better capital allocation decisions and improve well performance. The value chain typically starts with subsurface data acquisition and laboratory/measurement work on reservoir rock and fluids. The company then integrates those measurements into reservoir models and applies proprietary technologies to quantify flow behavior, damage mechanisms, and production enhancement options. Outputs are delivered as analytical deliverables, technology-enabled services, and related software/data products that support drilling design, completion optimization, and ongoing production troubleshooting.

A key operating feature is that the company participates in the ā€œdecision lifecycleā€ for upstream assets—moving from early reservoir understanding to later-cycle performance improvement—while building an increasingly reusable knowledge base tied to measured reservoir properties and validated methodologies.

šŸ’° Revenue Streams & Monetisation Model

Monetisation is driven by a mix of (1) technology-enabled, project-based consulting and laboratory services and (2) technology and data-related revenue that can recur as operators engage the firm across multiple assets or phases of field development. Margin drivers include:

  • Proprietary technology utilization: Higher-value engagements where clients pay for specific models, interpretation frameworks, and production enhancement pathways.
  • Lab and technical execution leverage: Repeatable workflows, standardized measurement/interpretation approaches, and scaling of trained technical capacity.
  • Recurring client ā€œworkstreamā€ development: While end markets are cyclical, many clients return when results are incorporated into reservoir decision-making and troubleshooting protocols.

Overall, revenue is not a pure subscription model, but the economics benefit when Core’s analytical outputs become embedded in customer reservoir models and operating processes.

🧠 Competitive Advantages & Market Positioning

Core’s moat centers on intangible assets and switching costs built from proprietary datasets, validated reservoir characterization methods, and a long history of domain-specific laboratory work. Competitors can match portions of technical capability, but replicating the full set of calibrated know-how and reference frameworks takes time and extensive validation.

Switching costs / data gravity: Once Core’s measurements and interpretations are integrated into an operator’s reservoir models—affecting well design assumptions, stimulation strategy, and production forecast logic—changing vendors typically requires rework, re-calibration, and re-validation of subsurface models. This creates an economic and technical friction that supports customer stickiness.

Intangible knowledge moat: The firm’s credibility and differentiation depend on accumulated subsurface experience and proprietary analytical frameworks, which benefit from cumulative learning and repeat application across asset types.

Competitive benchmarking:

  • Schlumberger (SLB): Broad integrated oilfield services provider with strong geoscience and reservoir capabilities across the project lifecycle.
  • Halliburton (HAL): Large footprint in stimulation, cementing, and subsurface services, competing for reservoir-to-well execution work.
  • Baker Hughes (BKR): Focus across equipment and services with competing offerings in subsurface characterization and production optimization.

Core’s positioning differs in emphasis: whereas large diversified service companies often deliver integrated solutions at scale, Core concentrates on high-value reservoir and production characterization where proprietary lab/analytics and interpretation frameworks can materially influence technical decisions. The competitive contrast is less about geographic field presence and more about depth of subsurface measurement, technology specificity, and model integration.

šŸš€ Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is supported by structural demand for better subsurface decisions rather than only incremental rig activity. Key drivers include:

  • Brownfield optimization: Mature fields increasingly require improved understanding of heterogeneity, wellbore damage, reservoir connectivity, and incremental recovery opportunities—areas where characterization and validation matter.
  • Enhanced oil recovery and complex reservoirs: Greater focus on EOR mechanisms and production challenges in tighter formations raises the value of measurement-grade reservoir understanding and flow diagnostics.
  • Digital and model-driven operations: Operators expand use of simulation, data integration, and analytics. Proprietary measurement workflows and validated interpretation frameworks can support more reliable model inputs.
  • Risk reduction for capital allocation: With cost pressure and lower tolerance for forecasting errors, operators pay for better subsurface certainty prior to major capital commitments.

The implied TAM expands as more assets move toward data-intensive development and troubleshooting phases, and as operators demand higher technical confidence in reservoir performance.

⚠ Risk Factors to Monitor

  • Upstream capital cycle volatility: Oil and gas operators manage spend tightly; project-based technical services can experience demand swings tied to commodity prices and E&P budgets.
  • Competitive substitution risk: Large diversified oilfield services players can bundle reservoir characterization with other offerings. Even when Core’s technology is preferred, budget trade-offs can shift workshare.
  • Technological and methodological obsolescence: Advancements in measurement, interpretation, and simulation can reduce the relative value of existing approaches if proprietary differentiation is not maintained.
  • Customer concentration and procurement cycles: Procurement processes at major operators can introduce timing and scale variability across asset programs.
  • Intellectual property and data integrity: The business depends on proprietary methods and accumulated knowledge; litigation, reputational risk, or data handling failures could affect competitiveness.
  • Operational execution in technical delivery: Laboratory quality, turnaround time, and interpretation rigor are central to client trust; execution issues can harm renewal probability.

šŸ“Š Valuation & Market View

Equity valuation in oilfield services and energy technology typically reflects earnings power through the cycle and the degree of defensibility in revenue mix. Markets often use EV/EBITDA and EV/EBIT as primary frameworks, while investors may assign incremental value when technology-like characteristics—such as proprietary intellectual capital, repeatable service delivery, and model-embedded outputs—reduce cyclicality.

Multiple expansion or contraction tends to track:

  • Visibility and renewal behavior: Evidence that client engagements extend across asset lifecycles.
  • Operating leverage: How efficiently fixed technical capacity converts into profit during upcycles.
  • Mix shift toward higher-value technology work: Greater share of specialty analytics and production enhancement rather than lower-margin commodity-like work.
  • Balance sheet and free cash flow resilience: Ability to fund capacity and technology while navigating industry downcycles.

šŸ” Investment Takeaway

Core Laboratories offers a differentiated, technology-led positioning in upstream reservoir and production optimization. The central investment thesis rests on intangible knowledge assets and customer switching costs created by embedding proprietary measurements and interpretations into operator reservoir models and decision workflows. While demand remains tied to upstream spending discipline, the durability of the technology-and-data moat supports the prospect of above-average long-term profitability if the company sustains validation, execution quality, and technological relevance against large integrated competitors.


⚠ AI-generated — informational only. Validate using filings before investing.

šŸ“° Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for CLB.

zacks.com•2026-07-31

Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?

Core Laboratories stock looks cheaper after a 47.1% six-month selloff, but falling earnings and geopolitical pressure keep the near-term case cautious.

zacks.com•2026-07-31

Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y

CLB's Q2 earnings top estimates despite lower revenues and profit as Production Enhancement strength offsets Reservoir Description weakness.

marketbeat.com•2026-07-31

Core Laboratories Q2 Earnings Call Highlights

Core Laboratories NYSE: CLB reported second-quarter 2026 revenue of $124.6 million, up more than 2% from the prior quarter but down 4% from a year earlier, as stronger completion-product sales partly offset disruptions to its service business from conflicts in the Middle East and Russia-Ukraine.

seekingalpha.com•2026-07-30

Core Laboratories Inc. (CLB) Q2 2026 Earnings Call Transcript

Core Laboratories Inc. (CLB) Q2 2026 Earnings Call Transcript

zacks.com•2026-07-29

Core Laboratories (CLB) Q2 Earnings Surpass Estimates

Core Laboratories (CLB) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.19 per share a year ago.

prnewswire.com•2026-07-29

CORE LAB REPORTS SECOND QUARTER 2026 RESULTS

REVENUE OF $ 124.6 MILLION, UP 2% SEQUENTIALLY AND DOWN 4% YEAR-OVER-YEAR OPERATING INCOME OF $ 9.2 MILLION; EX-ITEMS, $9.4 MILLION, UP 42% SEQUENTIALLY AND DOWN 36% YEAR-OVER-YEAR GAAP EARNINGS PER SHARE OF $0.13; EPS EX-ITEMS OF $0.11, UP 85% SEQUENTIALLY AND DOWN 42% YEAR-OVER-YEAR FREE CASH FLOW OF $ 3.1 MILLION COMPANY REPURCHASED 214,712 SHARES OF COMMON STOCK, FOR $2.7 MILLION AGGREGATE PURCHASE PRICE COMPANY ANNOUNCES Q3 2026 QUARTERLY DIVIDEND HOUSTON, July 29, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported second quarter 2026 revenue of $124,600,000. Core's operating income was $9,200,000, with earnings per diluted share ("EPS") of $0.13, all in accordance withĀ U.S. generally acceptedĀ accounting principles ("GAAP").

seekingalpha.com•2026-07-23

Ariel Small/Mid Cap Value Q2 2026 Portfolio Activity

The Ariel Small/Mid Cap Value Composite rose +15.08% gross of fees (+14.95% net of fees) in the quarter, falling short of both the Russell 2500 Value Index's +18.50% return and the +20.26% gain posted by the Russell 2500 Index. Live entertainment, media, and technology company, Sphere Entertainment Co. was the top contributor during the quarter on solid earnings and improving operating fundamentals. Shares of Prestige Consumer Healthcare moved lower following disappointing earnings, driven primarily by ongoing supply constraints in its eye care segment and extended lead times in the Middle East.

zacks.com•2026-07-23

What's in Store for Core Laboratories Stock in Q2 Earnings?

CLB's Q2 may reflect resilient international activity and tariff insulation, but weaker reservoir description results and higher costs could weigh.

zacks.com•2026-07-22

Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com•2026-07-20

Core Stock Down 39% in 6 Months: Should You Hold or Sell Now?

CLB struggles with ongoing headwinds from lower completion activity, operational disruptions, inflationary costs, weaker margins and projected earnings decline in 2026.

prnewswire.com•2026-06-30

CORE LABORATORIES ANNOUNCES TIMING OF SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL

HOUSTON, June 30, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its second quarter 2026 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m.

zacks.com•2026-06-09

Core Lab Stock Plunges 18% in 3 Months: Time to Hold or Fold?

CLB faces persistent geopolitical uncertainty, weaker laboratory activity, cost inflation and delayed shipments, limiting visibility into a stronger recovery.

gurufocus.com•2026-06-09

Arista Introduces Next-Generation 1.6Terabit Portfolio for AI Fabrics

Arista Networks (NYSE: ANET), a leader in modern AI fabric networking, today announced the Arista [url="]7060XE7 Series[/url], a new portfolio of 1.6T networki

zacks.com•2026-05-29

Core Laboratories (CLB) Down 4.9% Since Last Earnings Report: Can It Rebound?

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?

zacks.com•2026-05-21

Implied Volatility Surging for Core Laboratories Stock Options

Investors need to pay close attention to CLB stock based on the movements in the options market lately.

šŸ“Š AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-06-30

"On 2026-06-30 (Q2), Caliber/CLB reported Revenue of $124.6M and Net Income of $6.0M (EPS $0.13). QoQ, revenue rose from $121.8M (Q1) to $124.6M (+2.3%) while net income improved from a loss of -$0.8M to +$6.0M (turning profitable). YoY, revenue increased from $130.2M (Q2 2025) to $124.6M (-4.2% YoY) and net income declined from $10.6M (Q2 2025) to $6.0M (-44.0% YoY). Profitability was mixed. Net margin improved sequentially (from -0.6% in Q1 to 4.8% in Q2), but remained well below prior-year levels (Q2 2025 net margin 8.2%). Operating income rose QoQ to $9.2M, yet cash generation strengthened materially: operating cash flow increased to $7.8M and free cash flow to $12.7M in Q2. Balance sheet resilience appears stable with equity of $278.8M and total assets of $586.8M. Cash remains modest at $22.7M versus net debt of $16.6M, indicating manageable leverage. Shareholder returns were supportive from market momentum: the stock is up 33.9% over 1 year (above 20%), and CLB maintains a low dividend yield (~0.08%) with buybacks continuing (Q2 repurchased ~$2.7M). Analyst targets (median $26 vs. $16.5 price) suggest upside."

Revenue Growth

Fair

QoQ revenue +2.3% ($121.8M to $124.6M), but YoY revenue -4.2% ($130.2M to $124.6M), indicating a soft yearly trend.

Profitability

Positive

Net income turned positive QoQ (-$0.8M to +$6.0M) with net margin expanding to 4.8%, but YoY net income fell -44.0% (net margin down vs. 8.2% in Q2’25).

Cash Flow Quality

Good

Operating cash flow improved to $7.8M (from $4.0M in Q1) and free cash flow rose to $12.7M; dividends are modest and buybacks continue.

Leverage & Balance Sheet

Good

Equity remains stable and sizable ($278.8M). Leverage is manageable with net debt ~$16.6M and interest coverage ~3.2x; liquidity (current ratio ~2.1x) is solid.

Shareholder Returns

Strong

Total return tailwind from price momentum: 1y_change +33.9% (>20% threshold). Dividend yield is low (~0.08%), but repurchases were active (Q2 buybacks).

Analyst Sentiment & Valuation

Neutral

Consensus target median ~$26 vs. current ~$16.5 implies attractive upside; however, trailing valuation multiples appear elevated (P/E ~22x) given the mixed YoY earnings trend.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Core Labs’ Q2 2026 results show clear bifurcation: Reservoir Description is being pressured by geopolitical logistics and maritime disruption, while Production Enhancement continues to gain momentum through product-driven adoption. Total revenue was $124.6M (+2% sequentially, -4% YoY), but Reservoir Description revenue fell and margins dropped ~100 bps sequentially to ~5% as assay and reservoir characterization work lagged from Middle East and Russia/Ukraine conflicts. In contrast, Production Enhancement revenue rose 15% sequentially, with ex-item margins expanding from 5% in Q1 to 12% (+~700 bps), supported by higher energetic product sales and resolution of prior tax matters. Management also highlighted improved cost structure (service cost ratios and cost of sales) and continuing capital returns (214k shares repurchased for $2.7M; seventh consecutive buyback quarter). Q3 guidance implies sequential recovery in international regions and continued U.S. land completion improvement modestly, but with persistent geopolitical project timing risk. Sentiment is mixed due to ongoing disruption, offset by strengthening product/diagnostic demand.

AI IconGrowth Catalysts

  • Energetic completion product sales improved during the quarter, driven by increased operator adoption of Core Labs’ advanced completion technologies in both the U.S. and international markets
  • Production Enhancement margin expansion supported by higher product sales and strong adoption of newly commercialized InPulse perforating technology
  • Expanding diagnostic services adoption, including increased penetration of tracer-based completion diagnostic work in U.S. and international projects
  • Reservoir Description growth in international reservoir characterization, including new offshore exploration/appraisal work and carbon capture & storage projects (West Africa emphasized)

Business Development

  • Major international operator engaged Core Labs for reservoir characterization after a successful offshore Namibia exploration well
  • Core Labs initiated a reservoir characterization program supporting Murphy Oil’s recently announced discovery offshore CĆ“te d’Ivoire, using proprietary Dual Energy CT technology at the Houston Advanced Technology Center
  • U.S. West Texas operator used FLOWPROFILER oil and water tracer technology for stage-by-stage completion diagnostics
  • Louisiana major operator used gas tracer technology to validate sustained gas contribution across extended-length horizontal laterals
  • Western Canada independent operator engaged Core’s diagnostic technologies to evaluate and refine a multilateral water shutoff program

AI IconFinancial Highlights

  • Revenue: $124.6M in Q2 2026, +2% sequentially and -4% YoY; service revenue $94.3M flat sequentially and -2% YoY; product sales $30.3M +10% sequentially and -11% YoY
  • Reservoir Description: revenue -4% vs Q1 and -9% vs Q2 last year; operating margins (ex item) ~5%, down ~100 bps sequentially
  • Production Enhancement: revenue +15% sequentially; operating margins (ex item) 12%, up from 5% in Q1 (+~700 bps), aided by higher product sales and resolution of previously recorded tax matters
  • EBIT (ex items) $9.4M; EBIT margin ~8%, expanding 210 bps sequentially
  • EPS (diluted, ex items) $0.11 vs $0.06 in Q1 and $0.19 in Q2 last year; GAAP EPS $0.13
  • Partial refund of import tariffs in Q2 2026 (incurred in prior periods) contributed to improved cost of sales metrics
  • Effective tax rate projected ~25%; Q2 tax expense $1.6M (ex items) at 25%; GAAP tax expense $0.5M with discrete benefits

AI IconCapital Funding

  • Share repurchases: 214,000+ shares for $2.7M (Q2), continuing 7th consecutive quarter of buybacks
  • Dividend used alongside free cash flow (amount not quantified in transcript)
  • Balance sheet: cash $22.7M; net debt $93.6M; long-term debt $116.4M; leverage ratio 1.3x (vs 1.2x last quarter)
  • Free cash flow: $3.1M in Q2 after ~$4.7M CapEx; operating cash flow $7.8M
  • 2026 CapEx outlook (ex UK rebuild covered by insurance): $15M to $18M for full year

AI IconStrategy & Ops

  • Geopolitical disruptions (Middle East; Russia/Ukraine) drove project delays and logistical disruptions—largest impact on Reservoir Description via assay/reservoir characterization and sample acquisition constraints
  • Production Enhancement comparatively less affected; service activities and completion product shipments into the region experienced delays
  • Cost control: management referenced continuing cost reduction planning for Russia/Ukraine impacted business
  • Manufacturing and cost of services improvements: cost of services ex items 80% of service revenue (vs 81% Q1 and 77% last year); cost of sales ex items improved to 85% of revenue from 94% Q1
  • U.K. facility rebuild CapEx included $1.1M in Q2 (excluded from free cash flow per prior discussion); elevated CapEx tied to a multi-year Asia-Pacific contract and Mediterranean facility rebuilding

AI IconMarket Outlook

  • Q3 2026 revenue guidance: $128.5M to $135.5M; operating income $10.5M to $15.0M; operating margins ~10%
  • Q3 2026 EPS guidance: $0.12 to $0.20
  • Segment guidance Q3: Reservoir Description revenue $81M to $84M; operating income $5.5M to $7.9M; Production Enhancement revenue $47.5M to $51.5M; operating income $4.8M to $6.9M
  • Guidance assumptions: excludes FX gains/losses; assumes effective tax rate of 25%
  • Macro commentary: IEA/EIA/OPEC revised 2026 crude demand forecasts; demand growth projected to rebound by ~1.7M to 2.0M bpd in 2027; U.S. EIA production averages ~13.8M bpd in 2026

AI IconRisks & Headwinds

  • Middle East conflict and closure of Strait of Hormuz disrupting maritime hydrocarbon transportation—down global cargo movements vs pre-conflict by 16%
  • Russia/Ukraine escalation and sanctions increasing headwinds (refining/storage/transport site attacks; service revenue constrained by disrupted trading and maritime movement)
  • Crude assay and reservoir characterization sensitivity to field access and sample acquisition; project timing delays and logistical disruptions
  • Operator capital discipline and completion activity pacing may limit near-term service demand (noted continued emphasis on original 2026 execution plans)
  • Volatility in oil prices slowing trader activity and reducing predictability, impacting related assay/service demand

Q&A: Analyst Interest

  • Assay work disruption: Analyst asked how much non-Middle East/Russia-Ukraine movements offset reduced assay shipment logistics (including a hypothetical 25%-30% out-of-region exposure). Management cited global cargo movements down 16% vs pre-conflict and emphasized revenue capture at both ends of transactions (load and landfall) plus ongoing cost minimization without dismantling staffing.
  • Offshore project conviction rebound: Analyst queried whether increased customer conviction is returning for offshore reservoir characterization projects (after prior pricing/testing concerns). Management confirmed intensity of conversations has picked up, and tied earlier mixed outcomes to a period of committed work followed by dry holes; expects a late-2026 rebound into 2027.
  • InPulse/initial-completion recovery tie-in: Analyst referenced a prior U.S. recovery-boosting project/product requiring actions during initial completion and asked if it is InPulse. Management’s response was truncated in the transcript, but the prior narrative linked InPulse to improved near-wellbore connectivity and reduced breakdown pressures, enabling faster stage execution.

Sentiment: MIXED

Note: This summary was synthesized by AI from the CLB Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

šŸ“‹ Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for CLB.

SEC EDGAR Live Feed
Loading financial data and tables...
šŸ“

SEC Filings (CLB)

Ā© 2026 Stock Market Info — Core Laboratories N.V. (CLB) Financial Profile